BPS - Board of Pharmacy Specialties
Michelle Reinhardt PharmD, BCPP, serves as the Chief Scientific Officer at 406 Recovery since November 2022. Reinhardt is a Board Certified Psychiatric Pharmacist with the Board of Pharmacy Specialties since July 2016 and contributes as a Clinical Instructor for the Psychiatry Residency Program - Montana Track at the University of Washington since January 2019. Prior experience includes the role of Clinical Pharmacist Specialist in Psychiatry at Billings Clinic from August 2014 to November 2022, and completing a PGY2 Psychiatric Resident Pharmacist position at The University of Texas at Austin from July 2013 to June 2014, as well as a PGY1 Clinical Resident Pharmacist role at Billings Clinic from July 2012 to June 2013. Michelle Reinhardt earned a Doctor of Pharmacy degree from Roseman University of Health Sciences in 2012, completed post-baccalaureate prerequisites at the University of Nevada, Reno, and holds a Bachelor of Arts in Criminal Justice Pre Law from the same institution.
This person is not in any teams
This person is not in any offices
BPS - Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world. Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels. Through the rigorous standards mandated by BPS board certification and recertification, the BPS board certified pharmacist stands out as the most qualified to accept today’s expanding professional expectations.